Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Retail: 2 tablets, 5gm longUses
Some medications can enhance the anthelmintic properties of ciprofloxacin.
tell your doctor and pharmacist if you are allergic to ciprofloxacin, any other medications, or any of the ingredients in ciprofloxacin tablets. Ask your pharmacist for a list of the ingredients.
tell your doctor if you are taking or have recently taken riociguat (Adempas) or nitrates such as isosorbide dinitrate (Isordil), isosorbide mononitrate (Monoket), and nitroglycerin (Minitran, Nitro-Dur, Nitromist, Nitrostat, others). Nitrates come as tablets, sublingual (under the tongue) tablets, sprays, patches, pastes, and ointments. Ask your doctor if you are not sure whether any of your medications contain nitrates. Your doctor will probably tell you not to take tetracycline if you are taking nitrates.
tell your doctor if you are taking street drugs containing nitrates ('poppers') such as amyl nitrate, butyl nitrate, or nitrite while taking ciprofloxacin. Your doctor will probably tell you not to take ciprofloxacin if you are taking street drugs containing nitrates.
you should know that ciprofloxacin is available under the brand names Adcirca and Cipro. You should only be treated with one of these products at a time.
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: alpha blockers such as alfuzosin (Uroxatral), doxazosin (Cardura), dutasteride (Avodart, in Jalyn), prazosin (Minipress), silodosin (Rapaflo), tamsulosin (Flomax, in Jalyn), and terazosin; amiodarone (Cordarone, Pacerone); certain antifungals such as fluconazole (Diflucan), griseofulvin (Grifulvin, Gris-PEG), itraconazole (Onmel, Sporanox), ketoconazole (Extina, Ketozole, Nizoral, Xolegel), and voriconazole (Vfend); aprepitant (Emend); bosentan (Tracleer); carbamazepine (Carbatrol, Epitol, Tegretol, Teril, others); clarithromycin (Biaxin, in Prevpac); diltiazem (Cardizem, Cartia, Tiazac, others); efavirenz (Sustiva, in Atripla); erythromycin (E. E. S., E-Mycin, Erythrocin); HIV protease inhibitors including indinavir (Crixivan), nelfinavir (Viracept), and ritonavir (Norvir, in Kaletra), lovastatin (Altocor, in Advicor); medications for high blood pressure; nefazodone; nevirapine (Viramune); other medications or treatments for erectile dysfunction; other medications or treatments for PAH; phenobarbital; phenytoin (Dilantin, Phenytek); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane, in Rifamate, in Rifater); sertraline (Zoloft); telithromycin (Ketek); and verapamil (Calan, Covera, Verelan, in Tarka). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
tell your doctor what herbal products you are taking, especially St. John's wort.
tell your doctor if you smoke; if you have ever had an erection that lasted more than 4 hours; and if you have recently had diarrhea, vomiting, not been drinking enough fluids, or sweating a lot which may have caused dehydration (loss of a large amount of body fluids.
Kelley, D., & Schreiber, B. (2000). Ciprofloxacin renal clearance in renal failure: the significance of serum creatinine and serum potassium levels. Am J Kidney Disord, 13(5):853–859.
Schmitz, J. (2002). Renal pharmacokinetics in renal failure in patients with cystic fibrosis. Renal Pharmacokinet Res, 13(3):213–220.
Schmitt, D. (2003). A clinical update on the clinical status of ciprofloxacin. Antimicrob Agents Chemother, 20(4):566–579.
Schmitt, D., & Krummenger, R. Pharmacokinetics and pharmacodynamics of ciprofloxacin in patients with cystic fibrosis. Am J Kidney Disord, 15(8):741–750.
(2004). Renal clearance of ciprofloxacin in renal failure in patients with cystic fibrosis: a comparative analysis of plasma concentrations and serum concentrations. Clin Pharmacol Ther, 12(3):269–278.
(2006). The pharmacokinetics of ciprofloxacin in patients with cystic fibrosis: comparison with ciprofloxacin in normal subjects. Clin Pharmacokinet Rev, 9(1):73–89.
Ciprofloxacin renal clearance in normal and cystic fibrosis patients: a pilot study of the therapeutic effects on serum creatinine and creatinine clearance. Am J Kidney Disord, 16(3):222–265.
(2007). Pharmacokinetics of ciprofloxacin in the cystic fibrosis patient. A pilot study in renal failure. Am J Kidney Disord, 11(1):31–39.
Sjöstrand, L. (2001). Comparison of plasma concentrations of ciprofloxacin and cefprozil in patients with cystic fibrosis. Clin Pharmacokinet Rev, 10(6):367–373.
Sjöstrand, L., & Fruhst, D. Comparative pharmacokinetics of ciprofloxacin, cefprozil, and cefoperazene in patients with cystic fibrosis. Clin Pharmacokinet Rev, 11(1):69–79.
Comparative pharmacokinetics of ciprofloxacin, cefprozil, and cefoperazene in cystic fibrosis patients.
Clinical pharmacokinetics of ciprofloxacin in cystic fibrosis: comparison of pharmacokinetic parameters of the ciprofloxacin, cefprozil, and cefoperazene in normal subjects. Am J Kidney Disord, 15(2):163–173.
Krummenger, R., & Schmitt, D. (2005). Comparison of plasma concentrations of ciprofloxacin, cefprozil, and cefoperazene in cystic fibrosis: a pilot study of the therapeutic effects on serum creatinine and creatinine clearance. Clin Pharmacokinet Rev, 11(2):141–145.
Renal clearance of ciprofloxacin in patients with cystic fibrosis: a comparison of pharmacokinetic parameters of the ciprofloxacin, cefprozil, and cefoperazene in normal subjects.
Krummenger, R.
If you have any questions about the antibiotics that you may be taking, or your allergy, or about the allergy, you should ask your doctor or pharmacist. These may be your first symptoms or the first signs of an allergic reaction to ciprofloxacin. These are symptoms that may occur in your skin and in other areas of your body. They could also be symptoms you might not have even been aware of before. Your doctor may be able to tell you if you have allergies to any other medications you take, or if you have any other allergies or sensitivities. They can also help you know if you're taking ciprofloxacin to treat your,,,,,,,, or. You should know that ciprofloxacin (Cipro) is a prescription medication that doctors and other health care professionals take as a treatment for. It is used to treat a serious condition called, or inflammation of the lining of the small intestine (stalt cell). It can cause,,, and. Your doctor will probably start you on a low dose of ciprofloxacin and slowly increase it until you reach the prescribed dose.
Photograph: Anne-Marie Pugh, The New York PostThis article is part of a series calledCipro vs. Antibiotics.
There are other types of antibiotics, such as the fluoroquinolone antibiotics ciprofloxacin and levofloxacin. However, cipro is the only one that has been approved by the Food and Drug Administration to treat bacterial infections, although it hasn't been approved by the makers of antibiotics. This means that the drug will have to be approved before the problem that causes infection is found. Cipro has been shown to be safe for use in people with a certain immune system disorder and that the drug is not dangerous for people who have.
In addition, the drug is not approved for use in people who have, an autoimmune disorder that causes the inflammation of the, or, the immune system of the body. You should know that Cipro is a safe medicine for people who have,, and. The drug is safe for people who are at least 6 years old and older. You can read more about this.
You could be taking a combination of the drugs, but taking the ciprofloxacin combination medication, which also contains, is not dangerous for people who have these disorders. It is also not FDA-approved for use in people who have these disorders. These drugs include:
You may also be taking other medicines. These include:
You should know that you're not taking ciprofloxacin to treat your infections. This is because the medicine that helps your body eliminate ciprofloxacin from the body is used to treat bacterial infections and other inflammatory and, in particular, viral infections. Your doctor can check the level of ciprofloxacin in your blood to see if you have any signs of an allergic reaction to it.
You may also be taking another medicine to treat your, which is caused by a virus called. If you have any of the symptoms of a viral infection, including fever, chills, and, you should know that you're taking ciprofloxacin to treat your infections. The medicine that helps your body eliminate ciprofloxacin from the body, also called, may make your skin more sensitive to sunlight, which is a problem for many people.
Ciprofloxacin is available as an oral tablet or suspension.
Ciprofloxacin HCL is a broad-spectrum antibiotic belonging to the fluoroquinolone family. Ciprofloxacin is used for the treatment of various bacterial infections, including pharyngitis, tonsillitis, sinusitis, otitis media, peritonitis, biliary obstruction, and experimental pneumonium. It can also be used to treat urinary tract infections, including pyelonephritis, AL & BUN, skin infections, otitis media, intra-abdominal infections, and intra-abdominal infections. Ciprofloxacin HCL is used to treat various types of bacterial infections, such as urinary tract infections, bacterial vaginosis, intestinal infections, bone and joint infections, and respiratory and urinary tract infections. It can also be used to treat experimental infection of the skin and soft tissue, including post-myocarditis. It is also used for the treatment of anthrax inhalation exposure. Ciprofloxacin HCL may also be used to treat infections caused by susceptible strains of designated microorganisms in the genusSalmonellain clinical studies. However, as with any antibiotic, it is important to consult with a doctor before use if you have any reason to be concerned.
Ciprofloxacin HCL is used for the treatment of various bacterial infections, including pharyngitis, tonsillitis, tonsillitis, sinusitis, otitis media, peritonitis, biliary obstruction, and experimental pneumonium. Ciprofloxacin HCL may also be used for the treatment of infections caused by susceptible strains of designated microorganisms in the genus
The recommended dosage of Ciprofloxacin HCL for the treatment of pharyngitis, tonsillitis, tonsillitis, and peritonitis is 1 g daily for 7 days. The recommended dosage of Ciprofloxacin HCL for the treatment of experimental pneumonium, tonsillitis, and tonsillitis is 500 mg twice daily for 7 days. The dosage of Ciprofloxacin HCL for the treatment of biliary obstruction and biliary perforation is 500 mg twice daily for 7 days. The dosage of Ciprofloxacin HCL for the treatment of experimental pneumonium, tonsillitis, and tonsillitis is 500 mg twice daily for 7 days. The dosage of Ciprofloxacin HCL for the treatment of experimental pneumonium, tonsillitis, and tonsillitis is 500 mg daily for 7 days. The recommended dosage of Ciprofloxacin HCL for the treatment of experimental pneumonium, tonsillitis, and tonsillitis is 500 mg daily for 7 days.